Is Hexo Stock a Buy After Falling 94% Since April 2019?

Will Hexo stock go boom or bust by end of 2020?

| More on:
edit Jars of marijuana

Image source: Getty Images

Marijuana investors have seen a huge dip in their portfolio value over the last 12 months. Several of them were bullish on pot companies back in October 2018 when Canada legalized marijuana for recreational use. But everything that could go wrong did go wrong.

Cannabis companies, including Hexo (TSX:HEXO)(NYSE:HEXO) have been impacted by a thriving black market, regulatory issues, lower-than-expected demand, high inventory levels, and mounting losses. Hexo shares touched a record high of $11.1 back in April 2019 and have since lost a staggering 94% to currently trade at $0.64.

Hexo lost 27% in a single day this year

On March 30, Hexo announced its fiscal second quarter of 2020 results. It reported revenue of $17 million, which was 17% higher than its Q1 sales. Comparatively, it reported a net loss of a massive $298 million, which was lower than its Q1 net loss of $364 million. This indicated a loss per share of $1.13 in Q2.

In the second quarter, Hexo booked a couple of impairment charges. Hexo stopped production at its Niagara facility. This facility was acquired by Hexo in its Newstrike Brands deal. However, Hexo now wants to sell this facility and reported a goodwill impairment charge of $112 million.

Hexo produced 22,305 kg of cannabis product in Q2, up from 16,107 kg in Q1. However, the average selling price per gram fell from $4.35 to $3.49 in this period. These less-than-encouraging metrics did not impress investors and dragged the stock lower soon after its quarterly result.

Will Hexo follow Aurora Cannabis and enact a reverse stock split

Earlier this week, Aurora Cannabis enacted a reverse stock split to continue trading on the NYSE. According to NYSE’s listing rules, a company’s stock price cannot trade below $1 for more than 30 consecutive trading days. At the time of writing, Hexo was trading at $0.45. It fell below the $1 mark at the end of March and it might soon have to announce a reverse split to maintain trading status on the exchange.

Even if Hexo can bring its share price above $1, it is still grappling with structural issues. According to analyst Bill Kirk from MKM Partners, the Canadian market consumes 180,000 kg of pot annually. The total production of Canadian pot companies far exceeds this consumption. One major reason is the slow rollout of retail stores in major Canadian markets.

Will Cannabis 2.0 save pot companies?

Most cannabis producers, including Hexo, have been impacted by oversupply. However, we know that cannabis-infused edibles were legalized last year and were expected to drive sales in 2020. The COVID-19 pandemic has hurt sales of cannabis products due to countrywide lockdowns. But the long-term demand looks robust.

The North American market for cannabis-infused beverages is expected to be worth over $1.5 billion by 2026. Hexo has partnered with Molson Coors and will soon co-launch a THC-infused beverage in 2020. Hexo has the opportunity to target this high growth space, which might drive top-line growth in the upcoming decade.

The verdict

The cannabis industry is at a nascent stage. However, it is now a crowded space with multiple players trying to gain market share. These oversupply issues might hurt Hexo and peers over the next few quarters.

The multi-billion-dollar opportunity in cannabis is attractive for long-term investors. But there is a good chance that a few marijuana producers might go bankrupt before the market consolidates.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

The Motley Fool recommends HEXO. and HEXO. Fool contributor Aditya Raghunath has no position in any of the stocks mentioned.

More on Cannabis Stocks

edit Jars of marijuana
Cannabis Stocks

Is Tilray Stock a Buy in the New Bullish Market?

Canadian cannabis producer Tilray has underperformed the broader markets in the last five years due to its weak fundamentals.

Read more »

Bad apple with good apples
Cannabis Stocks

1 TSX Stock I Wouldn’t Touch With a 10-Foot Pole

Down 99% from all-time highs, Aurora Cannabis stock remains a high-risk bet due to its weak fundamentals and risky liquidity…

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Has Been on a Roller Coaster: Is it a Good Buy?

In their relatively small lifetime, most cannabis stocks in Canada have seen both extreme highs and massive slumps. But their…

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Canopy Growth Stock Surged 100% Last Month: Is It a Good Buy Now?

Canopy Growth soared more than 160% last month. Can the TSX cannabis stock continue to mover higher in 2024?

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Is Rising But I’m Worried About This One Thing

Canopy Growth stock is soaring as the legalization effort makes real progress in both Germany and the United States.

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Why Canopy Growth Stock Could Double in 2024

Canopy Growth (TSX:WEED) stock saw its share more than double in the last two weeks. So, can it do it…

Read more »

Coworkers standing near a wall
Cannabis Stocks

Why Is Everyone Talking About Canopy Growth Stock?

Canopy Growth stock (TSX:WEED) saw shares surge in the last two weeks for a variety of reasons investors can dig…

Read more »

Pot stocks are a riskier investment
Stocks for Beginners

Why Shares of Cannabis Stocks Are Rising This Week

Cannabis stocks received a boost this week as the White House urged the drug enforcement administration to reschedule the drug.

Read more »